Risedronate Sodium
These highlights do not include all the information needed to use safely and effectively. See full prescribing information for . Initial U.S. Approval: 1998
dddcd321-4d2e-4643-bf3c-7b752b33ba39
HUMAN PRESCRIPTION DRUG LABEL
Jan 31, 2022
Teva Pharmaceuticals USA, Inc.
DUNS: 001627975
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Risedronate Sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (11)
Risedronate Sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
Risedronate Sodium
Product Details
FDA regulatory identification and product classification information